Genix Receives Approval to Extend Warrants from the TSX Venture ExchangeJuly 28, 2022Vancouver, British Columbia, July 28, 2022 – Genix Pharmaceuticals Corporation (TSX-V: GENX; OTCQB: GENPF)…
Genix Proposes to Extend WarrantsJuly 20, 2022Vancouver, British Columbia, July 20, 2022 – Genix Pharmaceuticals Corporation…
Genix Pharmaceuticals Corporation Receives Natural Product Number for Rechlor from Health CanadaSeptember 8, 2021Vancouver, British Columbia, September 08, 2021 – Genix Pharmaceuticals Corporation (TSX-V: GENX; OTCQB: GENPF)…
Genix Pharmaceuticals Corp. Receives Approval for Drug Establishment LicenseJuly 15, 2021Vancouver, British Columbia, July 15th, 2021 – Genix Pharmaceuticals Corporation (TSX-V:…
Genix Pharmaceuticals Corp. Lists on the OTCQB Venture Market ExchangeJune 21, 2021Vancouver, British Columbia, June 21st, 2021 – Genix Pharmaceuticals Corporation…
Genix Pharmaceuticals Corporation Provides a Corporate Update To ShareholdersJune 7, 2021VANCOUVER, June 07, 2021 – Genix Pharmaceuticals Corporation (TSXV: GENX)…